Kygevi (doxecitine and doxribtimine) earned FDA approval as the first treatment for thymidine kinase 2 deficiency, supported by data from a Phase II trial and multiple retrospective studies showing ...

IMCIVREE now publicly covered for weight management due to Bardet-Biedl syndrome (BBS) in Ontario, Alberta, British Columbia, Saskatchewan, Nova Scotia and under NIHB ...

Congress must defend the independent work of inspectors general, who have saved taxpayers billions of dollars and provide essential oversight, from President Trump’s efforts to defund and ...

In the sun-drenched landscape of Mesa, Arizona sits a treasure trove that defies the ordinary shopping experience—a place where bargain hunters and thrift enthusiasts converge in pursuit of the ...

Modulator therapy does not appear to affect the magnitude of lung function impairment or recovery pattern during pulmonary ...

The life-saving technology was pioneered by Dr. Robert H. Bartlett, a thoracic surgeon and a UMich professor, who died Oct.

The Alliance for Clinical Trials in Oncology has launched a new clinical trial seeking to evaluate the feasibility of ...

An international research consortium co-led by scientists from Vanderbilt University Medical Center, the University of Toronto and University of Pittsburgh has mapped the functional impact of more ...

Access to nutritious food through SNAP slows cognitive decline, but barriers limit the program's reach and effectiveness on ...

Coinbase, the global cryptocurrency powerhouse, has launched a Maryland lobbying campaign to counter an order by state Attorney General Anthony Brown restricting it from offering investors a ...

The fate of Cursor and Replit and the rest could follow a number of paths. Cursor recently announced it is developing its own AI models focused on code, an apparent attempt to lessen its dependence on ...

We often encounter patients taking multiple medications, which complicates choosing safe and effective antimicrobial ...